Entera Bio (ENTX) Tax Provisions (2021 - 2024)

Entera Bio's (ENTX) quarterly Tax Provisions came in at $14000.0 in Q4 2024, down 51.72% on a QoQ basis from $29000.0 in Q3 2023.

Entera Bio (ENTX) Tax Provisions (2021 - 2024) Analysis & Trends

Entera Bio (ENTX) has 4 years of Tax Provisions data on file, last reported at $14000.0 in Q4 2024.

Quarterly Tax Provisions changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
Tax Provisions eased to $14000.0 in Q4 2024, from $29000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $194000.0 in Q3 2022 to a low of -$46000.0 in Q4 2022.
A 4-year average of $12100.0 and a median of -$10000.0 in 2021 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 1592.31% in 2022, down 206.67% in 2022.
Tracing ENTX's Tax Provisions over 4 years: stood at -$15000.0 in 2021, then sank by 206.67% to -$46000.0 in 2022, then surged by 163.04% to $29000.0 in 2023, then slumped by 51.72% to $14000.0 in 2024.
The last three Tax Provisions figures came in at $14000.0 (Q4 2024), $29000.0 (Q3 2023), and -$46000.0 (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	Entera Bio	162.20 Mn	150.89 Mn	-	-

Download Data